Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 24813298.
- Also identified by DOI 10.1016/j.jaad.2014.03.030 and PMC identifier 4410179.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.
Medical subject headings
- Anti-Infective Agents
- Dermatitis, Atopic
- Histamine Antagonists
- Immunologic Factors
- Phototherapy